Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease.
about
Host-microbe interactions shaping the gastrointestinal environmentEscherichia coli in Europe: an overviewTransitioning From Descriptive to Mechanistic Understanding of the Microbiome: The Need for a Prospective Longitudinal Approach to Predicting DiseaseThe role of the innate and adaptive immune system in pediatric inflammatory bowel disease.The first 1000 cultured species of the human gastrointestinal microbiota.Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicityHost defense peptide resistance contributes to colonization and maximal intestinal pathology by Crohn's disease-associated adherent-invasive Escherichia coli.Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?Review article: dietary fibre-microbiota interactions.Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies.Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.Role of the intestinal microbiota and fecal transplantation in inflammatory bowel diseases.Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers.Identification of Candidate Adherent-Invasive E. coli Signature Transcripts by Genomic/Transcriptomic AnalysisMicrobiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?The microbiome and childhood diseases: Focus on brain-gut axis.Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammationDysbiosis in the pathogenesis of pediatric inflammatory bowel diseases.Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.Acute Infectious Gastroenteritis Potentiates a Crohn's Disease Pathobiont to Fuel Ongoing Inflammation in the Post-Infectious Period.Convergence of External Crohn's Disease Risk Factors on Intestinal Bacteria.Campylobacter jejuni increases flagellar expression and adhesion of noninvasive Escherichia coli: effects on enterocytic Toll-like receptor 4 and CXCL-8 expression.Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell linesNASPGHAN single-topic symposium: discovering the future of pediatric IBD care.How does knowledge from translational research impact our clinical care of pediatric inflammatory bowel disease patients?Gazing into the crystal ball: future considerations for ensuring sustained growth of the functional food and nutraceutical marketplace.Gut microbiota in inflammatory bowel disease.The role of autophagy in Crohn's disease.The potential of FimH as a novel therapeutic target for the treatment of Crohn's disease.NOD2 induces autophagy to control AIEC bacteria infectiveness in intestinal epithelial cells.Influences of enteral nutrition upon CEACAM6 expression by intestinal epithelial cells.Pathogenic Role of Associated Adherent-Invasive Escherichia coli in Crohn's Disease.Lactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections.Microbiota, Immune Subversion, and Chronic Inflammation.Adherent-invasive Escherichia coli blocks interferon-γ-induced signal transducer and activator of transcription (STAT)-1 in human intestinal epithelial cells.A polymicrobial view of disease potential in Crohn's-associated adherent-invasive E. coli.Escherichia coli LF82 differentially regulates ROS production and mucin expression in intestinal epithelial T84 cells: implication of NOX1.Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury.A potential role of Escherichia coli pathobionts in the pathogenesis of pediatric inflammatory bowel disease.Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis.
P2860
Q26829479-CCCD9FD9-050C-47E0-A7CF-A49AE48DECA7Q27015697-4736F844-46D3-4739-952A-448A288DCC46Q33822244-B032180C-3C5B-4106-914D-BC2FB6F0FDC7Q33830707-65A0A0F6-602E-45EE-A0D3-F79DC459F3ADQ34041082-BC79807A-80F5-439D-9FF2-A551F6416A2EQ34048001-834D327C-8BE3-4725-9A69-EF76D4D9A701Q34058861-22A73E6F-631C-4F10-AE6C-B1950225B682Q34407175-1A717AC4-3E98-436C-9570-28A20BDC646FQ34477939-02F60FC7-EF9B-4CF1-B176-3F7D769F6BC6Q34786166-1733A073-D0B8-4E19-9B57-402E96BE4A23Q35271319-EB802DE5-A8CD-4A53-9D36-52252DCB7EB6Q35412079-90DFBBE6-906A-4F31-AC02-28BC15D1B269Q35544114-ECC8CBC2-2436-465C-9777-8B97269F60A3Q35678726-5E68412D-E50E-47BE-9348-6349B59B6630Q35801931-E3546380-AB2D-4E93-AA13-A46AC476E44CQ35878852-6A7386EE-889E-4056-9094-1C8226381F53Q35888267-D51E5DDB-ACC7-48B9-B258-5D77B098B0E5Q35997779-CD91482F-5D63-4126-BAD2-A494E9367B95Q36050474-026AA31D-118D-462D-A7EE-1456B09D767BQ36155351-53FEE6F2-7D76-40BB-963E-37B947475C54Q36242017-E1DB44CA-3BC1-490F-823A-733D888703D0Q36281342-4626E1AB-287F-42ED-80CF-89DA7E55327AQ37264192-8BFD00EC-BC84-41FD-92DF-A9AEDEC09B9BQ37467578-0A59ADC1-8D0F-48C1-898C-CC31FE58D723Q37994130-8CA83D16-980B-4237-B881-C8B3E8B5CB4BQ38096521-C8105637-8EA3-42B8-A47D-A2DD93D886E1Q38134755-87CDC8A0-BC26-417B-97F4-20C78EE839FDQ38202872-5B689DA0-A855-4B3C-824E-CB3BBAE964E0Q38648792-6EF9B3C7-8931-4049-8C87-48448E7AD0DBQ38762721-CDA48BCF-501C-4242-A0AC-6794DBE559E7Q39044637-0D77FB51-4960-4845-91BD-C809AE55F488Q39124653-E01F1AF6-7D38-4267-A30D-937A05F087D6Q39159902-3B4EA3D7-FECF-4BE7-B0C3-2355BFD44BB0Q39203697-D5726285-CEA4-455F-9638-09CD90B57805Q39258188-D2C665CF-E0EC-4725-8016-61481024E569Q40044097-D642446F-622F-4660-9192-8C42423B9742Q41371514-7B4F5D49-FBCB-483F-BC5C-320D3FEA3762Q41543377-1AFC445E-C213-4B23-A65A-010FAE1AA59FQ44693025-81B6A521-0FE3-4747-A628-741CEA78C8A2Q51479359-56252BB1-34CA-4336-8DE9-9B271D9F3B91
P2860
Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Characterization of adherent-i ...... th inflammatory bowel disease.
@en
Characterization of adherent-i ...... th inflammatory bowel disease.
@nl
type
label
Characterization of adherent-i ...... th inflammatory bowel disease.
@en
Characterization of adherent-i ...... th inflammatory bowel disease.
@nl
prefLabel
Characterization of adherent-i ...... th inflammatory bowel disease.
@en
Characterization of adherent-i ...... th inflammatory bowel disease.
@nl
P2093
P2860
P50
P921
P356
P1476
Characterization of adherent-i ...... th inflammatory bowel disease.
@en
P2093
Antonella Tinari
Fabio Minelli
Federica Nuti
Lucia Bertuccini
Maria Pierdomenico
P2860
P304
P356
10.1002/IBD.21899
P50
P577
2011-10-12T00:00:00Z